Background/Objectives: Metabolic dysfunction is increasingly recognised as a key contributor to heart failure with reduced ejection fraction (HFrEF), yet the underlying mechanisms remain incompletely understood. Therefore, robust animal models that recapitulate human HFrEF are needed for mechanistic investigation and t...
James Baudry, Yu-Jia Cao, Sultan Samman et al.· Biomedicines· 0 citations
BACKGROUND
In this research, 2-chloro-3-hydrazinylquinoxaline (CHQ) was evaluated for hepatoprotection and mechanism of action against the hepatotoxicity and liver inflammation in rats induced by the drug doxorubicin (DOX).
METHODS
Twenty-four male Wistar rats were split into four groups (n = 6 per group): normal con...
A. Azhari, N. Juma, N. Helmi et al.· Clinical Laboratory· 0 citations
Doxorubicin (DOX) is a powerful anthracycline anti-neoplastic agent, and its therapeutic application is frequently restricted because of its liver-damaging effects. In this study, we found that DOX induces acute liver toxicity in rats, and the mechanisms underlying these effects were investigated.
This study...
M. Alkasih, N. Juma, H. Niyazi et al.· Journal of Pharmacology and...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.